Workshop
Antibody Drug Discovery and Development: Hit Generation, Engineering, Cell-line Development, IND enabling studies, and Biosimilars
Speakers:
Donald McCarthy, Mohan Srinivasan, Guna Kannan, Erin Filbert, Deepali Sawant, Bo Yu, Nicola Stagg, Richard Boismenu
Organizers:
Donald McCarthy, Mohan Srinivasan, Wenfeng Xu
Date:
2019-11-12
Time:
8:45-17:00 Pacific Time
Registration fee:
(USD): Regular: $195; Academic: $125; For unemployed or students: $30; For vendor-show rep: $35; For major-sponsor rep (incl lunch): $0
Location:
SF Bay Area: Foster City Crowne Plaza
Major Sponsor:
Vendor show vendors registered to date:
(13)BioIVT; ChemPartner; Emerson Collective; Eurofins Discovery; Genscript USA; Intertek; JOINN Biologics; MabPlex USA, Inc.; MicroConstants; PHC former Panasonic Healthcare; Promega; R&D Systems; SCIEX
Registration: http://www.PBSS.org
Registration deadline:2019-11-10
(it will close sooner if the seating cap is reached)
About the Topic
Workshop Agenda:
8:45 - 9:00. PBSS Welcome Remarks - Shichang Miao
9:00 - 9:30. 1. Overview of Therapeutic mAbs - Donald McCarthy, Panorama Reserach Institute
9:30 - 10:30. 2. Antibody Discovery - Mohan Srinivasan, TRex Bio
10:30 - 10:40. Major Sponsor Presentation - Abzena
10:40 - 11:00. Break
11:00 - 12:00. 3. Antibody Engineering - Guna Kannan, Denali
12:00 - 12:30. 4. In-vitro Assays for Antibody Discovery & Development - Erin Filbert, Apexigen
12:30 - 1:30. Lunch
1:30 - 2:00. 5. In-vivo Models for Antibody Discovery & Clinical Efficacy - Deepali Sawant, Amgen
2:00 - 2:50. 6. Cell Line Development & CMC - Bo Yu
2:50 – 3:00. Major Sponsor Presentation - Cytovance Biologics
3:00 - 3:20. Break & Raffle
3:20 - 4:15. 7. IND Enabling Studies - Nicola Stagg, Genentech
4:15 – 5:00. 8. Biosimilars - Richard Boismenu, Coherus
5:00 – 5:30. 9. Panel Discussion - All Speakers
Organizing Committee: Donald McCarthy, Mohan Srinivasan, Wenfeng Xu
2024-04-26, [In-Person] Oncology Clinical Dose Optimization in Light of FDA Project Optimus
|
2024-05-06, [In-Person] Human Mass Balance and Metabolite Profiling Studies: Strategies, Technical Approaches, Regulatory Guidance, Applications and Case Studies
|
2024-05-13, [Free Online] Highlights of 2023 FDA Drug Approvals
|
2024-05-21, [In-Person] Nonclinical Safety Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
|
2024-05-30, [Free Online Workshop] Career Transition for Research Scientists: Career Overview, Project Management and Regulatory Affairs (jointly with BioPharmaPM and RAPS-SF)
|
2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
|
2024-06-20, Alzheimer's Disease: untangling what we thought we knew and future Precision Medicine Diagnostics and Therapeutics
|
2024-07-24, [Free Online] The Science and Stories of Promising Biotech Startups: Symposium No.6
|
2024-09-10, [In-Person] Rethinking Translational PK/PD and Human Dose Projections for Novel Therapeutic Modalities: Covalent Inhibitors, PROTACs, Molecular Glues, ADCs, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies
|
2024-09-20, [In-Person] Non-clinical safety assessments of biologics and novel modalities for IND/NDA Filing: Nuts, Bolts and Best Practices
|
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
|